BioXcel Therapeutics to Highlight Novel Approaches in AI-Based Drug Candidate Discovery and Development and Advances in Neuroscience Portfolio at Virtual R&D Day

BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO

R&D Day

Sep 23, 2021 • 12:00pm - 2:00pm EDT

Canaccord Genuity 41st Annual Growth Conference

Aug 12, 2021 • 9:30am EDT